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Background: To analyze the long-term spontaneous course of cardiac patients suffering from inflammatory cardiomyopathy (CMi) with 
persisting HHV-6 infections by follow-up biopsies. HHV-6 is a lymphotropic virus with life-long persistence, primarily associated with non-
cardiac diseases, and discussed as a possible etiologic factor of myocarditis and cardiomyopathy.
methods and results:  We prospectively evaluated patients (n=73) with biopsy-proven viral HHV-6 infection in endomyocardial biopsies 
(EMBs), followed up by reanalysis of EMBs and left ventricular ejection fraction (LV-EF) measurements after a median period of 8.8 
months (range 4 to 73 months). Beyond, we studied HHV-6 prevalence in isolated peripheral blood cells (PBCs) and HHV-6 species in 
EMBs. HHV-6 species-specific cellular infection sites within the myocardium were identified by immunohistochemistry (IHC). We identified 
73 patients with cardiac HHV-6 latency or newly detected in follow-up EMB (95.0% B). Systemic HHV-6 latency was primarily associated 
with A. Persistence of cardiac HHV-6 genome was significantly associated with cardiac dysfunction at follow-up (LV-EF deteriorated from 
58.2+16.0 to 51.8+17.2%, p<0.001), and LV improvement was observed when HHV-6 latency resolved (LV-EF increased from 54.9+15.4 to 
60.7+13.1%, p<0.001).
conclusion:  Persistence of cardiac HHV-6 genomes was significantly associated with cardiac dysfunction, and hemodynamic parameters 
improved in association with HHV-6 clearance.
